Mycenax Biotech Inc. (TPEX:4726)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.50
+0.20 (0.54%)
Apr 2, 2025, 1:30 PM CST

Mycenax Biotech Revenue

In the year 2024, Mycenax Biotech had annual revenue of 683.92M TWD with 4.80% growth. Mycenax Biotech had revenue of 193.99M in the quarter ending December 31, 2024, with 6.05% growth.

Revenue
683.92M
Revenue Growth
+4.80%
P/S Ratio
11.30
Revenue / Employee
1.77M
Employees
387
Market Cap
7.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024683.92M31.30M4.80%
Dec 31, 2023652.62M-79.66M-10.88%
Dec 31, 2022732.28M-41.99M-5.42%
Dec 31, 2021774.27M108.93M16.37%
Dec 31, 2020665.34M274.50M70.23%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition